PRESS RELEASE
-
S*BIO to initiate global phase 3 clinical trials of its novel JAK2 inhibitor
S*BIO explores partnering opportunities for advancement of its JAK2 program.
PRESS RELEASE | 25 October 2011
-
Bio-Images and Medimetrics partner to deliver the next generation of smart pill technology
IntelliCap set to speed up clinical research as part of innovative drug delivery package.
PRESS RELEASE | 25 October 2011
-
Sanofi appoints David Meeker Chief Executive Officer of Genzyme
Christopher A Viehbacher will retain the position of Chairman, Genzyme.
PRESS RELEASE | 24 October 2011
-
Abbott honored with Asian CSR award for leadership in science education
Abbott science education programs advance science learning for children in Asia and around the world.
PRESS RELEASE | 24 October 2011
-
ICON to support study evaluating variability in insulin secretory parameters
Selected by Biomarkers Consortium of the FNIH.
PRESS RELEASE | 21 October 2011
-
Biogen Idec and Elan receive notification of PDUFA date extension
Biogen Idec and Elan are working with the FDA to help facilitate a timely review of the REMS changes and the sBLA.
PRESS RELEASE | 20 October 2011
-
Agilent Technologies and University of Technology, Sydney, open joint nuclear magnet resonance facility
NMR facility will be home to cutting-edge technology to support a range of UTS staff and student research projects.
PRESS RELEASE | 20 October 2011
-
Bristol-Myers Squibb announces changes in senior management team
Giovanni Caforio has been promoted to President, US Pharmaceuticals.
PRESS RELEASE | 19 October 2011
-
Thermo Fisher Scientific screening library advances drug discovery research
20,000-molecule Maybridge collection will help identify compound candidates to treat a wide range of diseases.
PRESS RELEASE | 18 October 2011
-
AstraZeneca and Forest Laboratories to initiate phase 3 clinical trials for ceftazidime/avibactam
Treatment for serious Gram-negative bacterial infections.
PRESS RELEASE | 18 October 2011
